Pyxis Oncology, Inc. (PYXS)

Last Closing Price: 1.21 (2025-05-30)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Pyxis Oncology, Inc. (PYXS) had Net Income of $-77.33M for the most recently reported fiscal year, ending 2024-12-31.

Figures for fiscal year ending 2024-12-31
Income Statement Financials
$16.15M
Net Income
$-77.33M
$0.47M
$15.67M
$105.61M
$-89.46M
$9.96M
$-79.50M
$-79.50M
$-77.33M
$-77.33M
$-77.33M
$-77.33M
$-89.46M
$-92.59M
58.45M
58.45M
$-1.32
$-1.32
Balance Sheet Financials
$132.44M
$9.90M
$24.74M
$157.18M
$17.68M
--
$18.75M
$36.43M
$120.75M
$118.15M
$120.75M
59.97M
Cash Flow Statement Financials
$-57.67M
$8.15M
$59.33M
$11.14M
$20.95M
$9.81M
$12.95M
--
--
Fundamental Metrics & Ratios
7.49
--
--
--
--
97.06%
-554.07%
-554.07%
-573.44%
-492.35%
-478.95%
$-57.91M
--
--
--
0.10
--
--
--
-64.04%
-65.45%
-49.20%
-64.04%
$2.01
$-0.99
$-0.99